Interaction of anticancer Ru(III) complexes with single stranded and duplex DNA model systems(517 views) Musumeci D, Rozza L, Merlino A, Paduano L, Marzo T, Massai L, Messori L, Montesarchio D
Dalton T (ISSN: 1477-9226, 1477-9234, 1477-9226linking), 2015; 44(31): 13914-13925.
Department of Chemical Sciences, University of Napoli Federico II, Via Cintia 21, Napoli, Italy
Institute of Biostructures, Bioimages Via Mezzocannone 16, Napoli, Italy
References: Nardon, C., Boscutti, G., Fregona, D., Beyond platinums gold complexes as anticancer agents (2014) Anticancer Res., 34, pp. 487-49
Komeda, S., Casini, A., Next-generation anticancer metallodrugs (2012) Curr. Top. Med. Chem., 12, pp. 219-235
Bergamo, A., Gaiddon, C., Schellens, J.H., Beijnen, J.H., Sava, G., Approaching tumour therapy beyond platinum drugs: Status of the art and perspectives of ruthenium drug candidates (2012) J. Inorg. Biochem., 106, pp. 90-99
Ruiz-Azuara, L., Bravo-Gómez, M.E., Copper compounds in cancer chemotherapy (2010) Curr. Med. Chem., 17, pp. 3606-3615
Hartinger, C.G., Jakupec, M.A., Zorbas-Seifried, S., Groessl, M., Egger, A., Berger, W., Zorbas, H., Keppler, B.K., KP1019, a new redox-active anticancer agent-preclinical development and results of a clinical phase i study in tumor patients (2008) Chem. Biodiversity, 5, pp. 2140-2155
Alessio, E., Mestroni, G., Bergamo, A., Sava, G., Ruthenium antimetastatic agents (2004) Curr. Top. Med. Chem., 4, pp. 1525-1535
Ang, W.H., Casini, A., Sava, G., Dyson, P.J., Organometallic ruthenium-based antitumor compounds with novel modes of action (2011) J. Organomet. Chem., 696, pp. 989-998
Levina, A., Mitra, A., Lay, P.A., Recent developments in ruthenium anticancer drugs (2009) Metallomics, 1, pp. 458-470
Lentz, F., Drescher, A., Lindauer, A., Henke, M., Hilger, R.A., Hartinger, C.G., Scheulen, M.E., Jaehde, U., Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase i dose-escalation study (2009) Anticancer Drugs, 20, pp. 97-103
Rademaker-Lakhai, J.M., Van Den Bongard, D., Pluim, D., Beijnen, J.H., Schellens, J.H., A Phase i and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent (2004) Clin. Cancer Res., 10, pp. 3717-3727
Bergamo, A., Messori, L., Piccioli, F., Cocchietto, M., Sava, G., Biological role of adduct formation of the ruthenium(III) complex NAMI-A with serum albumin and serum transferrin (2003) Invest. New Drugs, 21, pp. 401-411
Webb, M.I., Walsby, C.J., Control of ligand-exchange processes and the oxidation state of the antimetastatic Ru(III) complex NAMI-A by interactions with human serum albumin (2011) Dalton Trans., 40, pp. 1322-1331
Kelland, L., The resurgence of platinum-based cancer chemotherapy (2007) Nat. Rev. Cancer, 7, pp. 573-584
Aitken, J.B., Antony, S., Weekley, C.M., Lai, B., Spiccia, L., Harris, H.H., Distinct cellular fates for KP1019 and NAMI-A determined by X-ray fluorescence imaging of single cells (2012) Metallomics, 4, pp. 1051-1056
Bergamo, A., Gagliardi, R., Scarcia, V., Furlani, A., Alessio, E., Mestroni, G., Sava, G., In vitro cell cycle arrest, in vivo action on solid metastasizing tumors, and host toxicity of the antimetastatic drug NAMI-A and cisplatin (1999) J. Pharmacol. Exp. Ther., 289, pp. 559-564
Malina, J., Novakov, O., Keppler, B.K., Alessio, E., Brabec, V., Biophysical analysis of natural, double-helical DNA modified by anticancer heterocyclic complexes of ruthenium(III) in cell-free media (2001) J. Biol. Inorg. Chem., 6, pp. 435-445
Pascu, G.I., Hotze, A.C.G., Sanchez-Cano, C., Kariuki, B.M., Hannon, M.J., Dinuclear ruthenium(II) triple-stranded helicates: Luminescent supramolecular cylinders that bind and coil DNA and exhibit activity against cancer cell lines (2007) Angew. Chem., Int. Ed., 46, pp. 4374-4378
Lai, H., Zhao, Z., Li, L., Zheng, W., Chen, T., Antiangiogenic ruthenium(II) benzimidazole complexes, structure-based activation of distinct signaling pathways (2015) Metallomics, 7, pp. 439-447
Pluim, D., Van Waardenburg, R.C., Beijnen, J.H., Schellens, J.H., Cytotoxicity of the organic ruthenium anticancer drug NAMI-A is correlated with DNA binding in four different human tumor cell lines (2004) Cancer Chemother. Pharmacol., 54, pp. 71-78
Bacac, M., Hotze, A.C., Van Der Schilden, K., Haasnoot, J.G., Pacor, S., Alessio, E., Sava, G., Reedijk, J., The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: An NMR evaluation (2004) J. Inorg. Biochem., 98, pp. 402-412
Velders, H., Bergamo, A., Alessio, E., Zangrando, E., Haasnoot, J.G., Casarsa, C., Cocchietto, M., Sava, G., Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl
4
(dmso-S)(dmtp)], (Na)[trans-RuCl
4
(dmso-S)(dmtp)], and [mer-RuCl
3
(H
2
O)(dmso-S)(dmtp)] (dmtp = 5,7-Dimethyl[1,2,4]triazolo[1,5-a]pyrimidine) (2004) J. Med. Chem., 47, pp. 1110-1121
Groessl, M., Zava, O., Dyson, P.J., Cellular uptake and subcellular distribution of ruthenium-based metallodrugs under clinical investigation versus cisplatin (2011) Metallomics, 3, pp. 591-599
Simeone, L., Mangiapia, G., Vitiello, G., Irace, C., Colonna, A., Ortona, O., Montesarchio, D., Paduano, L., Cholesterol-based nucleolipid-ruthenium complex stabilized by lipid aggregates for antineoplastic therapy (2012) Bioconjugate Chem., 23, pp. 758-770
Mangiapia, G., D'Errico, G., Simeone, L., Irace, C., Radulescu, A., Colonna, A., Montesarchio, D., Paduano, L., Ruthenium-based complex nanocarriers for cancer therapy (2012) Biomaterials, 33, pp. 3770-3378
Montesarchio, D., Mangiapia, G., Vitiello, G., Musumeci, D., Irace, C., Santamaria, R., D'Errico, G., Paduano, L., A new design for nucleolipid-based Ru(III) complexes as anticancer agents (2013) Dalton Trans., 42, pp. 16697-16708
Vitiello, G., Luchini, A., D'Errico, G., Santamaria, R., Capuozzo, A., Irace, C., Montesarchio, D., Paduano, L., Cationic liposomes as efficient nanocarriers for the drug delivery of an anticancer cholesterol-based ruthenium complex (2015) J. Mater. Chem. B, 3, pp. 3011-3023
Webb, M.I., Chard, R.A., Al-Jobory, Y.M., Jones, M.R., Wong, E.W.Y., Walsby, C.J., Pyridine analogues of the antimetastatic Ru(III) complex NAMI-A targeting non-covalent interactions with albumin (2012) Inorg. Chem., 51, pp. 954-966
Adhireksan, Z., Davey, G.E., Campomanes, P., Groessl, M., Clavel, C.M., Yu, H., Nazarov, A.A., Davey, C.A., Ligand substitutions between ruthenium-cymene compounds can control protein versus DNA targeting and anticancer activity (2014) Nat. Commun., 5, pp. 3462-3474
Groessl, M., Tsybin, Y.O., Hartinger, C.G., Keppler, B.K., Dyson, P.J., Ruthenium versus platinum: Interactions of anticancer metallodrugs with duplex oligonucleotides characterised by electrospray ionisation mass spectrometry (2010) J. Biol. Inorg. Chem., 15, pp. 677-688
Todd, R.C., Lippard, S.J., Structure of duplex DNA containing the cisplatin 1,2-{Pt(NH
3
)
2
}2+-d(GpG) cross-link at 1.77 Å resolution (2010) J. Inorg. Biochem., 104, pp. 902-908. , Unfortunately all the attempts we have carried out to obtain crystals of the same duplex metallated with the ruthenium complexes under investigation, suitable for X-ray diffraction analysis, have so far been unsuccessful
Alessio, E., Balducci, G., Calligaris, M., Costa, G., Attia, W.M., Mestroni, G., Synthesis, molecular structure, and chemical behavior of hydrogen trans-bis(dimethyl sulfoxide)tetrachlororuthenate(III) and mer-trichlorotris(dimethyl sulfoxide)ruthenium(III): The first fully characterized chloride-dimethyl sulfoxide-ruthenium(III) complexes (1991) Inorg. Chem., 30, pp. 609-618
Bouma, M., Nuijen, B., Jansen, M.T., Sava, G., Bult, A., Beijnen, J.H., Photostability profiles of the experimental antimetastatic ruthenium complex NAMI-A (2002) J. Pharm. Biomed. Anal., 30, pp. 1287-1296
Vargiu, V., Robertazzi, A., Magistrato, A., Ruggerone, P., Carloni, P., The hydrolysis mechanism of the anticancer ruthenium drugs NAMI-A and ICR investigated by DFT-PCM calculations (2008) J. Phys. Chem. B, 112, pp. 4401-4409
Ajibola Adigun, R., Martincigh, B., Nyamori, V.O., Omondi, B., Masimirembwac, C., Simoy, R.H., Kinetics and mechanistic investigation into the possible activation of imidazolium trans-[tetrachloridodimethylsulfoxideimidazoleruthenate(III)], NAMI-A, by 2-mercaptoethane sulfonate (2014) Dalton Trans., 43, pp. 12943-12951
Leijen, S., Burgers, S.A., Baas, P., Pluim, D., Tibben, M., Van Werkhoven, E., Alessio, E., Schellens, J.H.M., Preliminary Phase II studies in combination with gemcitabine in non-small cell lung cancer patients (2015) Invest. New Drugs, 33, pp. 201-214
Vergara, A., D'Errico, G., Montesarchio, D., Mangiapia, G., Paduano, L., Merlino, A., Interaction of anticancer ruthenium compounds with proteins: High-resolution X-ray structures and raman microscopy studies of the adduct between hen egg white lysozyme and AziRu (2013) Inorg. Chem., 52, pp. 4157-4159
Messori, L., Merlino, A., Ruthenium metalation of proteins: The X-ray structure of the complex formed between NAMI-A and hen egg white lysozyme (2014) Dalton Trans., 43, pp. 6128-6131
Interaction of anticancer Ru(III) complexes with single stranded and duplex DNA model systems